Advanced Medical Isotope changes name

Medical isotope developer Advanced Medical Isotope has changed its name to...Read more on AuntMinnie.comRelated Reading: AMIC reports progress on RadioGel FDA clearance AMIC resubmits Y-90 RadioGel to FDA AMIC nets brachytherapy-related patent AMIC looks for European investors AMIC and GSG form strategic alliance
Source: Headlines - Category: Radiology Source Type: news

Related Links:

To evaluate acute and late genitourinary toxicity, the gastrointestinal toxicity, and the long-term biochemical control after high-dose-rate (HDR) monotherapy in one fraction (20.5  Gy).
Source: Brachytherapy - Category: Cancer & Oncology Authors: Source Type: research
Hany S Hamza, Abdelrahman M ElhusseinyMiddle East African Journal of Ophthalmology 2018 25(2):65-70 Uveal melanoma is the most common intraocular malignant tumor, with the choroid being the most common site. Management of choroidal melanoma has evolved greatly over the past years. In the past, the conventional method of treatment was enucleation of the affected eye with a debate regarding the effect of enucleation to promote or prevent metastasis. However, nowadays, there are many therapeutic options available including plaque radiotherapy, proton beam radiotherapy, argon laser photocoagulation, transpupillary thermothera...
Source: Middle East African Journal of Ophthalmology - Category: Opthalmology Authors: Source Type: research
CONCLUSIONS: The majority of patients maintained good visual acuity, with no enucleations and minimal side effects. In this cohort, the Ru-106 plaque brachytherapy proved to be an efficacious and safe treatment option for patients with medium-sized choroidal melanomas with a maximal tumor height of 5 mm.
Source: Middle East African Journal of Ophthalmology - Category: Opthalmology Authors: Source Type: research
AbstractFor patients with inoperable liver metastases, intra-operative liver high dose-rate brachytherapy (HDR-BT) is a  promising technology enabling delivery of a high radiation dose to the tumor, while sparing healthy tissue. Liver brachytherapy has been described in the literature as safe and effective for the treatment of primary or secondary hepatic malignancies. It is preferred over other ablative techniques for lesions that are either larger than 4 cm or located in close proximity to large vessels or the common bile duct. In contrast to external beam radiation techniques, organ movements do not affect t...
Source: Strahlentherapie und Onkologie - Category: Cancer & Oncology Source Type: research
To determine women's experiences of brachytherapy for cervical cancer.
Source: Radiography - Category: Radiology Authors: Tags: Review article Source Type: research
ConclusionsIn the present era of HDR-ICBT with CCRT, radiation treatment longer than 8  weeks does not appear to make a significant impact on clinical outcomes. This is a retrospective analysis. Further studies are warranted.
Source: Journal of Radiation Oncology - Category: Cancer & Oncology Source Type: research
Brachytherapy (BT) is a vital component of the curative treatment of locally advanced cervical cancer. The American Brachytherapy Society has published guidelines for high dose rate (HDR) BT with recommended d...
Source: Radiation Oncology - Category: Cancer & Oncology Authors: Tags: Research Source Type: research
AbstractBackgroundThe aim of this work was to confirm that post-selective internal radiation therapy (SIRT)90Y-PET/CT-based dosimetry correlates with lesion metabolic response and to determine its correlation with overall survival (OS) in liver-only metastases from colorectal cancer (mCRC) patients treated with SIRT. Twenty-four mCRC patients underwent pre/post-SIRT FDG-PET/CT and post-SIRT90Y-PET/CT. Lesions delineated on pre/post-SIRT FDG-PET/CT were classified as non-metabolic responders (total lesion glycolysis (TLG)-decrease Dmean-under-treated) and in the “under-treated” group (at least one lesion receive...
Source: EJNMMI Research - Category: Radiology Source Type: research
This study compared five nomograms to clinical data from dynamic modified-peripheral intraoperative PSI to determine (a) the cause of excess seeds and (b) the optimal nomogram for our institution. Pre- and intraoperative patient data were collected for monotherapy PSIs and compiled into a clinical database. All patients were prescribed 125 Gy with dose coverage of D90% = 100% to the planning target volume (PTV) using 103 Pd seeds with mean air-kerma strength (SK¯) of 2 U. Seeds were ordered based upon an in-house nomogram as a function of preoperative prostate volume and prescription dose. Preopera...
Source: Journal of Applied Clinical Medical Physics - Category: Physics Authors: Tags: J Appl Clin Med Phys Source Type: research
CONCLUSIONS: The 2D in vivo rectal dosimetry using the ERB with EBT3 films was effective and might be clinically applicable for HDR brachytherapy for cervical and prostate cancers to monitor treatment accuracy and consistency as well as to predict rectal toxicity. PMID: 30004264 [PubMed - as supplied by publisher]
Source: Acta Oncologica - Category: Cancer & Oncology Authors: Tags: Acta Oncol Source Type: research
More News: Brachytherapy | Radiology